Please login to the form below
RENOIR
This page shows the latest RENOIR news and features for those working in and with pharma, biotech and healthcare.
Pfizer’s RSV vaccine granted EC approval to protect infants and older adults
The EC's decision, which follows a recent recommendation from the European Medicines Agency’s human medicines committee, was supported by positive results from the late-stage MATISSE and RENOIR trials. ... At an interim analysis of the ongoing RENOIR
Latest news
-
Pfizer’s RSV vaccine approved by FDA for older adults
US. Pfizer’s application was supported by results from the ongoing phase 3 RENOIR trial, designed to assess the efficacy, immunogenicity and safety of a single dose of the vaccine – to
-
Pfizer’s RSV vaccine candidate for older adults backed by FDA Advisory Committee
The VRBPAC’s decision on Pfizer’s candidate was supported by results from the phase 3 RENOIR trial, designed to assess the efficacy, immunogenicity and safety of a single dose of
-
Pfizer’s RSV vaccine candidate accepted for FDA priority review for use in older adults
Pfizer’s application is supported by results from the phase 3 RENOIR trial, a global, randomised, double-blind, placebo-controlled study designed to assess the efficacy, immunogenicity, and safety of a
-
Pfizer announces positive phase 3 results of RSV vaccine candidate in older adults
The phase 3 RENOIR trial is a global, randomised, double-blind, placebo-controlled study designed to assess the efficacy, immunogenicity and safety of a single dose of RSVpreF in adults 60
-
Pfizer receives Breakthrough Therapy Designation from FDA for RSV vaccine candidate
Pfizer announced the launch of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunised against RSV disease) in September 2021 – a phase 3 clinical trial evaluating the efficacy, immunogenicity, and safety of
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
